Sorrento Therapeutics, Inc. (SRNEQ)
OTCMKTS: SRNEQ · Delayed Price · USD
0.0100
+0.0020 (25.00%)
Mar 28, 2024, 11:54 AM EDT - Market open

Sorrento Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2009
Net Income
-572.84-428.33-298.46-292.07-203.549.13-60.92-45.81-34.66-21.91
Upgrade
Depreciation & Amortization
17.4816.3214.7115.049.497.142.892.373.181.29
Upgrade
Share-Based Compensation
74.8590.1931.4212.656.214.954.746.973.941.79
Upgrade
Other Operating Activities
186.664092.891.3876.07-120.4-17.63-5.6-1.232.34
Upgrade
Operating Cash Flow
-293.86-281.82-159.54-173-111.77-99.18-70.93-42.07-28.76-16.49
Upgrade
Capital Expenditures
-13.66-8.87-6.53-11.44-11.2-10.97-6.86-3.71-0.59-0.42
Upgrade
Acquisitions
-14.86-36.05-33.4-26.73-10-5.56-10.5927.7600.43
Upgrade
Change in Investments
0124.7700000-11.5-100
Upgrade
Other Investing Activities
----------0.51
Upgrade
Investing Cash Flow
-28.5279.85-39.92-38.17-21.2-16.53-17.4512.55-10.59-0.5
Upgrade
Share Issuance / Repurchase
403.53217.25416.2256.5583.8257.9392.871.772.0937.72
Upgrade
Debt Issued / Paid
-92.24-35.91-186.9822.34242.18-3.2438.87-3.17.56.85
Upgrade
Other Financing Activities
0.43--55---1.01--1.95--1
Upgrade
Financing Cash Flow
311.72181.33174.2478.8932653.68131.74-3.3579.5943.57
Upgrade
Exchange Rate Effect
-2.370.840.92-0.28-0.140.070000
Upgrade
Net Cash Flow
-10.66-20.64-25.22-132.28193.04-62.0343.36-32.8640.2426.58
Upgrade
Free Cash Flow
-307.51-290.69-166.06-184.44-122.96-110.15-77.79-45.78-29.36-16.91
Upgrade
Free Cash Flow Margin
-489.37%-549.47%-415.31%-586.78%-580.20%-72.54%-954.22%-997.30%-767.45%-3675.87%
Upgrade
Free Cash Flow Per Share
-0.73-0.99-0.72-1.39-1.16-1.58-1.54-1.24-1.10-1.12
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).